RU2006128735A - AGING COMPOSITION - Google Patents

AGING COMPOSITION Download PDF

Info

Publication number
RU2006128735A
RU2006128735A RU2006128735/15A RU2006128735A RU2006128735A RU 2006128735 A RU2006128735 A RU 2006128735A RU 2006128735/15 A RU2006128735/15 A RU 2006128735/15A RU 2006128735 A RU2006128735 A RU 2006128735A RU 2006128735 A RU2006128735 A RU 2006128735A
Authority
RU
Russia
Prior art keywords
aging
aging composition
composition according
coenzyme
formula
Prior art date
Application number
RU2006128735/15A
Other languages
Russian (ru)
Inventor
Кендзи ФУДЗИИ (JP)
Кендзи ФУДЗИИ
Таизо КАВАБЕ (JP)
Таизо КАВАБЕ
Хироси КУБО (JP)
Хироси КУБО
Кенити ХИГУТИ (JP)
Кенити ХИГУТИ
Original Assignee
Канека Корпорейшн (Jp)
Канека Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Канека Корпорейшн (Jp), Канека Корпорейшн filed Critical Канека Корпорейшн (Jp)
Publication of RU2006128735A publication Critical patent/RU2006128735A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (7)

1. Композиция против старения, содержащая в качестве активного ингредиента восстановленный коэнзим Q, представленный следующей формулой (1):1. An anti-aging composition comprising, as an active ingredient, reduced coenzyme Q represented by the following formula (1):
Figure 00000001
Figure 00000001
 в этой формуле n обозначает целое число от 1 до 12.in this formula, n denotes an integer from 1 to 12. 2. Композиция против старения по п.1, где восстановленный коэнзим Q представляет собой восстановленный коэнзим Q10. 2. The anti-aging composition according to claim 1, wherein the reduced coenzyme Q is a reduced coenzyme Q 10. 3. Композиция против старения по п.1, содержащая окисленный коэнзим, представленный следующей формулой (2):3. The anti-aging composition according to claim 1, containing the oxidized coenzyme represented by the following formula (2):
Figure 00000002
Figure 00000002
 в этой формуле n обозначает целое число от 1 до 12.in this formula, n denotes an integer from 1 to 12. 4. Композиция против старения по п.3, где окисленный коэнзим Q представляет собой окисленный коэнзим Q10. 4. The anti-aging composition according to claim 3, where the oxidized coenzyme Q is an oxidized coenzyme Q 10. 5. Композиция против старения по пп.1-4, где содержание восстановленного коэнзима Q находится в диапазоне от 0,001 до 99 мас.%.5. The anti-aging composition according to claims 1 to 4, wherein the content of reduced coenzyme Q is in the range from 0.001 to 99% by weight. 6. Способ предотвращения старения животных, включающий введение животному композиции против старения по любому из пп.1-5.6. A method of preventing the aging of animals, comprising administering to the animal an anti-aging composition according to any one of claims 1-5. 7. Способ получения композиции против старения, включающий смешивание восстановленного коэнзима Q, представленного следующей формулой:7. A method of obtaining a composition against aging, comprising mixing reduced coenzyme Q, represented by the following formula:
Figure 00000001
Figure 00000001
 с подходящими добавками, в этой формуле n обозначает целое число от 1 до 12.with suitable additives, in this formula n denotes an integer from 1 to 12.
RU2006128735/15A 2004-01-08 2005-01-07 AGING COMPOSITION RU2006128735A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004-002863 2004-01-08
JP2004002863 2004-01-08

Publications (1)

Publication Number Publication Date
RU2006128735A true RU2006128735A (en) 2008-02-20

Family

ID=34747062

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006128735/15A RU2006128735A (en) 2004-01-08 2005-01-07 AGING COMPOSITION

Country Status (10)

Country Link
EP (1) EP1701716A1 (en)
JP (1) JP2007517761A (en)
KR (1) KR20060134057A (en)
CN (1) CN1909895A (en)
AU (1) AU2005204044B2 (en)
CA (1) CA2550186A1 (en)
NO (1) NO20063144L (en)
RU (1) RU2006128735A (en)
TW (1) TW200526193A (en)
WO (1) WO2005065672A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007028997A (en) * 2005-07-27 2007-02-08 Kanebo Seiyaku Kk Liquid food mixed with crude drug essence and use of the same
JPWO2007034852A1 (en) 2005-09-22 2009-03-26 株式会社カネカ Life prolonging composition and method for extending life
US8962684B2 (en) 2009-09-29 2015-02-24 Shiseido Company, Ltd. Antioxidant composition
US20130195925A1 (en) * 2011-11-03 2013-08-01 Vaskin, Llc Anti aging application and method for treating aging
WO2015163443A1 (en) * 2014-04-25 2015-10-29 ヤクルトヘルスフーズ株式会社 Agent for delaying appearance of physical symptoms associated with aging
CN104474527B (en) * 2014-11-24 2015-10-07 南京泛成生物化工有限公司 A kind of compositions containing yeast rich in selenium and application thereof
CN111603552A (en) * 2020-07-02 2020-09-01 中健智诊(重庆)生物研究院 Anti-aging composition and application thereof
CN111973477A (en) * 2020-09-04 2020-11-24 湖南御家化妆品制造有限公司 Preparation method of idebenone and microcrystalline cellulose composite carrier and cosmetic

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5366435A (en) * 1976-11-19 1978-06-13 New England Inst Immunologically preventing method for phenomena of aging
NZ338026A (en) * 1997-03-27 2001-09-28 Michael J Sole Nutritional composition comprising L-carnitine, ubiquione and taurine and use for treating organ systems
IT1304406B1 (en) * 1998-10-21 2001-03-19 Danital Italia S R L PREPARATION FOR THE VEHICULATION OF ACTIVE INGREDIENTS BASED ON POLYUNSATURATED ACIDIGIDS OF THE OMEGA GROUP 3.
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6403116B1 (en) * 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US6506915B1 (en) * 2001-06-14 2003-01-14 Daniel David West Synthesis of coenzyme Q10 ubiquinone
TWI329513B (en) * 2001-10-12 2010-09-01 Kaneka Corp Use of reduced coenzyme q for lessening oxidative stress
JP2003135022A (en) * 2001-10-31 2003-05-13 Crescendo Corporation Coenzyme q10
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
US7438903B2 (en) * 2003-06-06 2008-10-21 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10

Also Published As

Publication number Publication date
TW200526193A (en) 2005-08-16
JP2007517761A (en) 2007-07-05
NO20063144L (en) 2006-10-09
CA2550186A1 (en) 2005-07-21
CN1909895A (en) 2007-02-07
EP1701716A1 (en) 2006-09-20
AU2005204044A1 (en) 2005-07-21
AU2005204044B2 (en) 2010-07-22
KR20060134057A (en) 2006-12-27
WO2005065672A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
RU2006128735A (en) AGING COMPOSITION
RU2370485C2 (en) Amidoacetonitrile derivatives
EP2277595A3 (en) Compounds for immunopotentiation
EP2279670A3 (en) Compositions containing fluorine substituted olefins
EA200701625A1 (en) 5-ALCOXYLKYL-6-ALKYL-7-AMINOAZOZOLOPIRIMIDINY, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION FOR FIGHTING PATHOGENIC MUSHRIA, AND ALSO CONTAINING THEIR MEANS
EP2361503A3 (en) N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
EP2409570A3 (en) Fungicidal mixtures based on pyrazolopyridine compounds
CY1113011T1 (en) NEW Crystalline Form V of Agomelatin, Its Preparation Method and Pharmaceutical Compositions Containing It
EP2386204A3 (en) Plant disease controlling composition and method for controlling plant disease
EP1604989A8 (en) DPP-IV inhibitors
WO2006074087A3 (en) Methods for enhancing the palatability of compositions for consumption by animals
EP2255627A3 (en) Fungicidal mixtures
ATE453685T1 (en) POLYMER COMPOSITION
EP2893930A3 (en) Compounds for enhancing erythropoiesis
MX2010005602A (en) Use of active ingredient combinations for controlling animal parasites.
ZA200809714B (en) Synergistic active ingredient combinations
DE602005011687D1 (en) Cosmetic mask composition
PL1970372T3 (en) Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols
DK1830861T3 (en) Antiviral and immunostimulating marine fish oil preparation
JP2005029789A5 (en)
EP1780237A3 (en) Composition for stabilizing polyolefin polymers
EA200602065A1 (en) RADIO SENSOR
AR060155A1 (en) COMBINATIONS OF ACTIVE PRINCIPLES WITH INSECTICIDES AND ACARICIDES
EP1609775A3 (en) 1-acetoxy-3-(substituted phenyl) propen compounds useful as an intermediate material
RU2007115892A (en) METHOD FOR PRODUCING 2-CHLORO-4-NITROIMIDAZOLE